Skip to main content
logo
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.33
-0.14 (-2.16%)
Feb 11, 2026, 4:00 PM EST - Market closed

Cartesian Therapeutics Revenue

Cartesian Therapeutics had revenue of $452.00K in the quarter ending September 30, 2025, with 16.80% growth. This brings the company's revenue in the last twelve months to $1.09M, down -97.72% year-over-year. In the year 2024, Cartesian Therapeutics had annual revenue of $38.91M with 49.64% growth.

Revenue (ttm)
$1.09M
Revenue Growth
-97.72%
P/S Ratio
153.17
Revenue / Employee
$16,530
Employees
66
Market Cap
165.64M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M68.48M412.60%
Dec 31, 202016.60M9.92M148.57%
Dec 31, 20196.68M5.77M639.42%
Dec 31, 2018903.00K696.00K336.23%
Dec 31, 2017207.00K-7.88M-97.44%
Dec 31, 20168.08M2.07M34.47%
Dec 31, 20156.01M2.97M97.73%
Dec 31, 20143.04M1.56M105.54%
Dec 31, 20131.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Editas Medicine46.38M
C4 Therapeutics30.11M
Prelude Therapeutics10.50M
Compugen6.90M
Molecular Partners AG856.30K
Revenue Rankings

RNAC News

More News